KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astrana Health (ASTH) Long-Term Debt Repayments (2016 - 2025)

Astrana Health's Long-Term Debt Repayments history spans 12 years, with the latest figure at $147000.0 for Q1 2025.

  • For Q1 2025, Long-Term Debt Repayments fell 17.88% year-over-year to $147000.0; the TTM value through Mar 2025 reached $638000.0, down 8.86%, while the annual FY2024 figure was $670000.0, 0.74% down from the prior year.
  • Long-Term Debt Repayments for Q1 2025 was $147000.0 at Astrana Health, up from $136000.0 in the prior quarter.
  • Across five years, Long-Term Debt Repayments topped out at $235.8 million in Q2 2021 and bottomed at -$238.0 million in Q4 2021.
  • The 5-year median for Long-Term Debt Repayments is $149000.0 (2023), against an average of $133000.0.
  • The largest YoY upside for Long-Term Debt Repayments was 120585.23% in 2024 against a maximum downside of 88944.55% in 2024.
  • A 5-year view of Long-Term Debt Repayments shows it stood at -$238.0 million in 2021, then skyrocketed by 98.68% to -$3.2 million in 2022, then soared by 105.39% to $170000.0 in 2023, then decreased by 20.0% to $136000.0 in 2024, then rose by 8.09% to $147000.0 in 2025.
  • Per Business Quant, the three most recent readings for ASTH's Long-Term Debt Repayments are $147000.0 (Q1 2025), $136000.0 (Q4 2024), and -$179.5 million (Q3 2024).